Gracell Biotechnologies Inc Key Opinion Leader Webinar on Multiple Myeloma Transcript

May 22, 2023 / 01:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Gracell Biotechnologies key opinion leader webinar on relapsed/refractory multiple myeloma. (Operator Instructions) I will now turn the conference call over to Dr. Kevin Xie, CFO. Please go ahead, sir.

Yili Xie - Gracell Biotechnologies Inc. - CFO

Good morning, and welcome to Gracell's key opinion leader webinar on relapsed refractory multiple myeloma. With me today are Gracell's Founder and Chief Executive Officer, Dr. William Cao; and Chief Medical Officer, Dr. Wendy Li; as well as Dr. Saad Usmani the esteemed myeloma and the cellular therapy expert and the Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center in New York City.

Gracell's CEO, Dr. William Cao will start by providing a brief recap on our lead candidate, GC012F and our upcoming U.S. trial for RRMM.

Wei Cao - Gracell Biotechnologies Inc. - Founder, Chairman & CEO

Thank you, Kevin. And again, welcome, everyone, to our KOL webinar. I will commence today's webinar by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot